Author | Ezra Cohen, MD

Articles

Immunotherapeutic Approaches to the Management of Head and Neck Cancer

December 17, 2018

Experts discuss the PD-1 checkpoint inhibitors nivolumab and pembrolizumab in the management of head and neck cancer, and how to choose between them.